Plasmatic Levels of Osteoprotegerine and RANKL after Alendronate Treatment on Women with Postmenopausal Osteoporosis

被引：0
|
作者：
Garcia-Mendoza, A. [1 ]
Nieto-Serrano, R. [1 ]
Martin-Garcia, A. [1 ]
Robles-Barba, J. [1 ]
Cepedello-Boiso, I. [1 ]
Tendero-Gomez, R. [1 ]
Reyes-Garcia, R. [1 ]
Padilla-Bolivar, O. [1 ]
机构：
[1] HU San Cecilio, Granada, Spain
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2005年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S249 / S249
页数：1
相关论文
共 50 条
  • [1] Effects of alendronate treatment on serum levels of osteoprotegerin and total RANKL in women with postmenopausal osteoporosis
    Reyes-García, R
    Fernández-García, D
    Mezquita-Raya, P
    De la Higuera, M
    Alonso, G
    Ruiz-Requena, ME
    Escobar-Jiménez, F
    Muñoz-Torres, M
    BONE, 2005, 36 : S410 - S411
  • [2] Cyclical alendronate treatment in postmenopausal women with osteoporosis
    Kösüs, A
    Çapar, M
    Kösüs, N
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2005, 91 (02) : 182 - 184
  • [3] Effect of alendronate in postmenopausal women with systemic osteoporosis treatment
    Povoroznyuk, Vladyslav V.
    Orlyk, Tatyana V.
    Dzerovych, Nataliya I.
    BONE, 2008, 42 : S83 - S84
  • [4] Ten years of alendronate treatment for osteoporosis in postmenopausal women
    Chan, AS
    NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (02): : 190 - 190
  • [5] iPTH levels in postmenopausal women with osteoporosis treated with alendronate.
    Massari, F
    Zanchetta, JR
    JOURNAL OF BONE AND MINERAL RESEARCH, 1997, 12 : S470 - S470
  • [6] Alendronate in the treatment of postmenopausal osteoporosis
    Hosking, DJ
    Favus, M
    Yates, AJ
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 1999, : 27 - 35
  • [7] Compliance with alendronate 10 treatment in elderly women with postmenopausal osteoporosis
    Sewerynek, Ewa
    Dabrowska, Katarzyna
    Skowronska-Jozwiak, Elibieta
    Zygmunt, Arkadiusz
    Lewinski, Andrzej
    ENDOKRYNOLOGIA POLSKA, 2009, 60 (02) : 76 - 81
  • [8] Treatment of osteoporosis in postmenopausal women: Alendronate vs intranasal calcitonin
    Rosen, CJ
    Bonnick, SL
    Miller, PD
    Palmisano, J
    OSTEOPOROSIS INTERNATIONAL, 2000, 11 : S197 - S197
  • [9] ORAL ALENDRONATE AND INTRANASAL CALCITONIN IN THE TREATMENT OF OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN
    ADAMI, S
    LOMBARDI, A
    ORTOLANI, S
    PASSERI, M
    CAPIZZI, T
    JOURNAL OF BONE AND MINERAL RESEARCH, 1995, 10 : S254 - S254
  • [10] Focus on alendronate: A nonhormonal option for the treatment of osteoporosis in postmenopausal women
    Ashworth, L
    FORMULARY, 1996, 31 (01) : 23 - &
12345